EIB supports Irish Neuromod Devices
EIB has participated in a €30 million ($32.9 million) financing of Neuromod Devices to further commercialise its tinnitus treatment device,...
EIB has participated in a €30 million ($32.9 million) financing of Neuromod Devices to further commercialise its tinnitus treatment device,...